LEVODOPA 50 mg /12.5 Mg/200 Mg Film-Coated Tablets

Зміст інструкції

1. Levodopa/Carbidopa/Entacapone Teva 50 mg/12.5 mg/200 mg film-coated tablets, 75 mg/18.75 mg/200 mg film-coated tablets, 100 mg/25 mg/200 mg film-coated tablets, 125 mg/31.25 mg/200 mg film-coated tablets
   1. What is Levodopa/Carbidopa/Entacapone Teva and what is it used for
   2. What you need to know before taking Levodopa/Carbidopa/Entacapone Teva
   3. How to take Levodopa/Carbidopa/Entacapone Teva
   4. Possible side effects
   5. How to store Levodopa/Carbidopa/Entacapone Teva
   6. Contents of the pack and other information

Levodopa/Carbidopa/Entacapone Teva 50 mg/12.5 mg/200 mg film-coated tablets, 75 mg/18.75 mg/200 mg film-coated tablets, 100 mg/25 mg/200 mg film-coated tablets, 125 mg/31.25 mg/200 mg film-coated tablets

Levodopa/Carbidopa/Entacapone Teva 150 mg/37.5 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Teva 175 mg/43.75 mg/200 mg film-coated tablets
Levodopa/Carbidopa/Entacapone Teva 200 mg/50 mg/200 mg film-coated tablets
Generic medicine

Read this leaflet carefully before you start taking this medicine as it contains important
information for you.

• Keep this leaflet. You may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others, even if their symptoms are the same as yours, as it could be harmful.
• If you get any side effects, even those not listed in this leaflet, tell your doctor or pharmacist. See section 4.

Contents of this leaflet

• 1. What Levodopa/Carbidopa/Entacapone Teva is and what it is used for
• 2. What you need to know before you take Levodopa/Carbidopa/Entacapone Teva
• 3. How to take Levodopa/Carbidopa/Entacapone Teva
• 4. Possible side effects
• 5. How to store Levodopa/Carbidopa/Entacapone Teva
• 6. Contents of the pack and other information

1. What is Levodopa/Carbidopa/Entacapone Teva and what is it used for

Levodopa/Carbidopa/Entacapone Teva contains three active ingredients (levodopa, carbidopa and entacapone) in a
film-coated tablet. Levodopa/Carbidopa/Entacapone Teva is used for the treatment of
Parkinson's disease.
Parkinson's disease is caused by low levels of a substance called dopamine in the brain. Levodopa increases
the amount of dopamine and thus reduces the symptoms of Parkinson's disease. Carbidopa and
entacapone improve the antiparkinsonian effects of levodopa.

2. What you need to know before taking Levodopa/Carbidopa/Entacapone Teva

Do not take Levodopa/Carbidopa/Entacapone Teva:

• If you are allergic to levodopa, carbidopa, entacapone or any of the other ingredients of this medicine (listed in section 6).
• If you have closed-angle glaucoma (an eye disease)
• If you have a tumor of the adrenal gland
• If you are taking medicines to treat depression (combinations of MAO-A and MAO-B selective inhibitors, or non-selective MAO inhibitors)
• If you have ever had neuroleptic malignant syndrome (NMS, this is a rare reaction to medicines used to treat serious mental disorders)
• If you have ever had non-traumatic rhabdomyolysis (a rare muscle disorder)
• If you have severe liver disease.

Warnings and precautions
Talk to your doctor or pharmacist before taking Levodopa/Carbidopa/Entacapone Teva if you have or have ever
had:

• a heart attack or any other heart disease, including cardiac arrhythmias, or blood vessel disease
• asthma or any other lung disease
• liver problems, because your dose may need to be adjusted
• kidney or hormonal problems
• stomach ulcers or convulsions
• if you experience prolonged diarrhea, consult your doctor, as it may be a sign of colon inflammation
• any form of severe mental disorder such as psychosis
• chronic open-angle glaucoma, because your dose may need to be adjusted and your eye pressure kept under medical control.

Talk to your doctor if you are taking:

• antipsychotics (medicines used to treat psychosis)
• a medicine that may cause low blood pressure when getting up from a chair or bed. You should know that Levodopa/Carbidopa/Entacapone Teva may worsen these reactions.

Talk to your doctor if during treatment with Levodopa/Carbidopa/Entacapone Teva:

• you notice that your muscles become very stiff or contract violently, or if you suffer from tremors, agitation, confusion, fever, increased heart rate or large fluctuations in blood pressure. If any of the above cases occur, contact your doctor immediately
• you feel depressed, have suicidal thoughts or notice unusual changes in your behaviour
• you fall asleep suddenly or feel very sleepy. In this case, you should not drive or use tools or machinery (see also section 'Driving and using machines').
• you notice that uncontrolled movements start or worsen after you have started taking Levodopa/Carbidopa/Entacapone Teva. In this case, your doctor may want to change the dose of your anti-Parkinsonian medicines.
• you experience diarrhea: monitoring body weight is recommended to avoid potentially excessive weight loss
• you have progressive anorexia, asthenia (weakness, feeling exhausted) and weight loss within a relatively short period of time. In this case, a general medical examination including a liver function test should be considered.
• if you feel the need to stop using Levodopa/Carbidopa/Entacapone Teva, see section 'If you stop taking Levodopa/Carbidopa/Entacapone Teva'.

Tell your doctor if you or your family/caregiver notice the development of impulses or strong
desires to behave in a way that is unusual for you, or if you cannot resist the impulse, desire or temptation to
perform certain activities that could harm you or others. These behaviours are called
impulse control disorders and may include pathological gambling, compulsive eating, compulsive shopping, increased libido or hypersexuality. Your doctor may want to review
your treatment.
During long-term therapy with Levodopa/Carbidopa/Entacapone Teva your doctor may want to subject you to
regular laboratory tests.
If you are to undergo surgery, tell your doctor that you are taking
Levodopa/Carbidopa/Entacapone Teva.
Levodopa/Carbidopa/Entacapone Teva is not recommended for use in the treatment of
extrapyramidal symptoms (e.g. involuntary movements, tremors, muscle rigidity and muscle contractions) caused by
other medicines.

Children and adolescents
Experience with levodopa/carbidopa/entacapone in patients under 18 years of age is limited. The use of
Levodopa/Carbidopa/Entacapone Teva is not recommended in these patients.

Other medicines and Levodopa/Carbidopa/Entacapone Teva
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other
medicines.
Do not take Levodopa/Carbidopa/Entacapone Teva if you are taking certain medicines for the treatment of
depression (combinations of MAO-A and MAO-B selective inhibitors or non-selective MAO inhibitors).
Levodopa/Carbidopa/Entacapone Teva may enhance the effects and side effects of some medicines.
These include:

• medicines used to treat depression, such as moclobemide, amitriptyline, desipramine, maprotiline, venlafaxine and paroxetine
• rimiterol and isoprenaline, used to treat respiratory diseases
• adrenaline, used to treat severe allergic reactions
• noradrenaline, dopamine and dobutamine, used to treat heart disease and low blood pressure
• alpha-methyldopa, used to treat high blood pressure
• apomorphine, used to treat Parkinson's disease.

The effects of Levodopa/Carbidopa/Entacapone Teva may be reduced by some medicines. These
include:

• dopamine antagonists used to treat mental disorders, nausea and vomiting
• phenytoin, used to prevent seizures
• papaverine, used to relax muscles.

Levodopa/Carbidopa/Entacapone Teva may make it more difficult to absorb iron. Therefore, do
not take Levodopa/Carbidopa/Entacapone Teva and iron supplements at the same time. After taking
either one, wait at least 2 to 3 hours before taking the other.

Levodopa/Carbidopa/Entacapone Teva with food and drink
Levodopa/Carbidopa/Entacapone Teva can be taken with or without food. In some patients,
Levodopa/Carbidopa/Entacapone Teva may not be well absorbed if it is taken with, or immediately after
consuming protein-rich foods (such as meat, fish, dairy products, seeds and nuts). If you think this is the
case, consult your doctor.

Pregnancy, breastfeeding and fertility
If you are pregnant, suspect you are pregnant or are planning to become pregnant, or if you are breastfeeding
with breast milk, ask your doctor or pharmacist for advice before taking this medicine.
During treatment with Levodopa/Carbidopa/Entacapone Teva you should not breastfeed.

Driving and using machines
Levodopa/Carbidopa/Entacapone Teva may lower blood pressure, causing confusion or
dizziness. Therefore, be particularly careful when driving or using any tools or
machinery.
If you experience drowsiness or sudden sleep attacks, wait until you are fully awake
before driving or performing any other activity that requires attention. Otherwise you could put
yourself or others at risk of injury or death.

[50 mg/12,5 mg/200 mg, 75 mg/18,75 mg/200 mg, 125 mg/31,25 mg/200 mg, 175 mg/43,75 mg/200 mg

and 200 mg/50 mg/200 mg]

Levodopa/Carbidopa/Entacapone Tevacontains lactose.
If your doctor has diagnosed you with intolerance to certain sugars, contact him/her before taking this
medicine.

Levodopa/Carbidopa/Entacapone Teva100 mg/25 mg/200 mg contains lactose and Allura Red
(E129).
If your doctor has diagnosed you with intolerance to certain sugars, contact him/her before taking this
medicine.
Allura Red (E129) may cause allergic reactions.

Levodopa/Carbidopa/Entacapone Teva150 mg/37,5 mg/200 mg contains lactose and carmoisine
(E122).
If your doctor has diagnosed you with intolerance to certain sugars, contact him/her before taking this
medicine.
Carmosine (E122) may cause allergic reactions.

3. How to take Levodopa/Carbidopa/Entacapone Teva

Take this medicine following exactly the instructions of your doctor or pharmacist. If you have
any doubts, ask your doctor or pharmacist.
Adults and the elderly:

• Your doctor will tell you exactly how many Levodopa/Carbidopa/Entacapone Teva tablets to take each day.
• The tablets must not be divided or broken into smaller pieces.
• You must take only one tablet at a time.
• Depending on how you respond to treatment, your doctor may suggest a higher or lower dose.
• If you are taking Levodopa/Carbidopa/Entacapone Teva tablets of 50 mg/12.5 mg/200 mg, 75 mg/18.75 mg/200 mg, 100 mg/25 mg/200 mg, 125 mg/31.25 mg/200 mg or 150 mg/37.5 mg/200 mg, do not take more than 10 tablets a day.
• If you are taking Levodopa/Carbidopa/Entacapone Teva tablets of 175 mg/43.75 mg/200 mg, do not take more than 8 tablets of this dose a day.
• If you are taking Levodopa/Carbidopa/Entacapone Teva tablets of 200 mg/50 mg/200 mg, do not take more than 7 tablets of this dose a day.

Consult your doctor or pharmacist if you think that the effect of Levodopa/Carbidopa/Entacapone Teva is too
strong or too weak, or if you experience any possible side effects.

If you take more Levodopa/Carbidopa/Entacapone Tevathan you should
If you have accidentally taken more Levodopa/Carbidopa/Entacapone Teva tablets than you should, inform
your doctor or pharmacist immediately. In case of overdose, you may feel confused or agitated, your
heart rate may slow down or become faster than normal, or the color of your skin, tongue, eyes or
urine may change.

If you forget to take Levodopa/Carbidopa/Entacapone Teva
Do not take a double dose to make up for the missed tablet.
If more than 1 hour is left until the next dose:
Take a tablet as soon as you remember, and the next tablet at the usual time.
If less than 1 hour is left until the next dose:
Take a tablet as soon as you remember, wait 1 hour, then take another tablet. After
continue as usual.
To avoid possible side effects, always leave at least one hour between successive doses of
Levodopa/Carbidopa/Entacapone Teva.

If you stop taking Levodopa/Carbidopa/Entacapone Teva
Do not stop taking Levodopa/Carbidopa/Entacapone Teva unless your doctor tells
you to. In this case, your doctor may want to adjust the dose of your other anti-Parkinson medicines, in
particular levodopa, to give you sufficient control of your symptoms. If you suddenly stop treatment
with Levodopa/Carbidopa/Entacapone Teva and other anti-Parkinson medicines, this may cause side
effects.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Many of the side effects can be alleviated by adjusting the dose.
If you experience the following symptoms during treatment with Levodopa/Carbidopa/Entacapone Teva, contact your
doctor immediately:

• the muscles become very rigid or contract violently, you suffer from tremors, agitation, confusion, fever, increased heart rate or large fluctuations in blood pressure. These may be symptoms of neuroleptic malignant syndrome (NMS, a rare serious reaction to medicines used to treat central nervous system disorders) or rhabdomyolysis (a rare serious muscle disorder).
• Allergic reaction: signs may include hives, itching, skin rash, swelling of the face, lips, tongue or throat, which can cause difficulty breathing or swallowing.

Very common: may affect more than 1 in 10 people

• uncontrolled movements (dyskinesia)
• feeling unwell (nausea)
• harmless reddish-brown discoloration of the urine
• muscle pain
• diarrhea

Common: may affect up to 1 in 10 people

• dizziness or fainting caused by low blood pressure, increased blood pressure
• worsening of Parkinson's symptoms, dizziness, drowsiness
• vomiting, pain and discomfort in the abdomen, heartburn, dry mouth, constipation
• insomnia, hallucinations, confusion, abnormal dreams (including nightmares), fatigue
• mental disorders including memory problems, anxiety and depression (possibly with suicidal thoughts)
• cardiac or cardiovascular events (e.g. chest pain), irregular heart rate or rhythm
• increased frequency of falls
• shortness of breath
• increased sweating, skin rash
• muscle cramps, swelling of the legs
• blurred vision
• anemia
• loss of appetite, weight loss
• headache, joint pain
• urinary tract infection

Uncommon: may affect up to 1 in 100 people

• heart attack
• intestinal bleeding
• changes in blood cells that can cause bleeding, abnormalities in liver function tests
• convulsions
• feeling of agitation
• psychotic symptoms
• colitis (inflammation of the colon)
• change in color of skin, nails, hair, sweat
• difficulty swallowing
• inability to urinate

The following side effects have also been reported:

• hepatitis (inflammation of the liver)
• itching

You may experience the following side effects:

• Inability to resist the urge to perform an action that could be harmful, including:
• a strong urge to gamble excessively despite serious financial or personal consequences
• a change or increase in sexual interest and behavior that is significantly concerning to you or to others, for example increased libido
• excessive and uncontrollable shopping or spending
• compulsive eating (consuming large amounts of food in a short period of time) or uncontrolled eating (consuming more food than normal and more than is needed to satisfy hunger).

Inform your doctor if any of these behaviors occur; your doctor will inform you about ways to
manage or reduce the symptoms.

Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your doctor
or pharmacist. You can also report side effects directly through the national reporting system at
http://www.aifa.gov.it/content/segnalazioni-reazioni-avverse . By reporting side effects, you can help provide more
information on the safety of this medicine.

5. How to store Levodopa/Carbidopa/Entacapone Teva

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bottle and the carton after SCAD.
The expiry date refers to the last day of that month.
This medicine does not require any particular storage conditions.
Validity after first opening of the bottle: 175 days.
Do not dispose of any medicine in waste water or household waste. Ask your pharmacist how to eliminate the
medicines that you no longer use. This will help to protect the environment.

6. Contents of the pack and other information

What Levodopa/Carbidopa/Entacapone Teva contains
The active ingredients of Levodopa/Carbidopa/Entacapone Teva are levodopa, carbidopa and entacapone.

• Each Levodopa/Carbidopa/Entacapone Teva film-coated tablet containing 50 mg/12.5 mg/200 mg contains 50 mg of levodopa, 12.5 mg of carbidopa and 200 mg of entacapone.
• The other components of the tablet core are microcrystalline cellulose, anhydrous lactose, low substitution hydroxypropylcellulose, povidone (K-30), anhydrous colloidal silica and magnesium stearate
• The components of the coating are titanium dioxide (E171), hypromellose, glycerol (E422), yellow iron oxide (E172), polysorbate 80, red iron oxide (E172), black iron oxide (E172) and magnesium stearate.

The active ingredients of Levodopa/Carbidopa/Entacapone Teva are levodopa, carbidopa and entacapone.

• Each Levodopa/Carbidopa/Entacapone Teva film-coated tablet containing 75 mg/18.75 mg/200 mg contains 75 mg of levodopa, 18.75 mg of carbidopa and 200 mg of entacapone.
• The other components of the tablet core are microcrystalline cellulose, anhydrous lactose, low substitution hydroxypropylcellulose, povidone (K-30), anhydrous colloidal silica and magnesium stearate
• The components of the coating are titanium dioxide (E171), hypromellose, glycerol (E422), yellow iron oxide (E172), polysorbate 80, red iron oxide (E172) and magnesium stearate.

The active ingredients of Levodopa/Carbidopa/Entacapone Teva are levodopa, carbidopa and entacapone.

• Each Levodopa/Carbidopa/Entacapone Teva film-coated tablet containing 100 mg/25 mg/200 mg contains 100 mg of levodopa, 25 mg of carbidopa and 200 mg of entacapone.
• The other components of the tablet core are microcrystalline cellulose, anhydrous lactose, low substitution hydroxypropylcellulose, povidone (K-30), anhydrous colloidal silica and magnesium stearate
• The components of the coating are titanium dioxide (E171), hypromellose, glycerol (E422), polysorbate 80, Allura red aluminum lake (E129), carmine (E120) and magnesium stearate.

The active ingredients of Levodopa/Carbidopa/Entacapone Teva are levodopa, carbidopa and entacapone.

• Each Levodopa/Carbidopa/Entacapone Teva film-coated tablet containing 125 mg/31.25 mg/200 mg contains 125 mg of levodopa, 31.25 mg of carbidopa and 200 mg of entacapone.
• The other components of the tablet core are microcrystalline cellulose, anhydrous lactose, low substitution hydroxypropylcellulose, povidone (K-30), anhydrous colloidal silica and magnesium stearate
• The components of the coating are titanium dioxide (E171), hypromellose, glycerol (E422), yellow iron oxide (E172), polysorbate 80, red iron oxide (E172) and magnesium stearate.

The active ingredients of Levodopa/Carbidopa/Entacapone Teva are levodopa, carbidopa and entacapone.

• Each Levodopa/Carbidopa/Entacapone Teva film-coated tablet containing 150 mg/37.5 mg/200 mg contains 150 mg of levodopa, 37.5 mg of carbidopa and 200 mg of entacapone.
• The other components of the tablet core are microcrystalline cellulose, anhydrous lactose, low substitution hydroxypropylcellulose, povidone (K-30), anhydrous colloidal silica and magnesium stearate
• The components of the coating are titanium dioxide (E171), hypromellose, glycerol (E422), polysorbate 80, red iron oxide (E172), carmoisine aluminum lake (E122) and magnesium stearate.

The active ingredients of Levodopa/Carbidopa/Entacapone Teva are levodopa, carbidopa and entacapone.

• Each Levodopa/Carbidopa/Entacapone Teva film-coated tablet containing 175 mg/43.75 mg/200 mg contains 175 mg of levodopa, 43.75 mg of carbidopa and 200 mg of entacapone.
• The other components of the tablet core are microcrystalline cellulose, anhydrous lactose, low substitution hydroxypropylcellulose, povidone (K-30), anhydrous colloidal silica and magnesium stearate
• The components of the coating are titanium dioxide (E171), hypromellose, glycerol (E422), yellow iron oxide (E172), polysorbate 80, red iron oxide (E172), black iron oxide (E172) and magnesium stearate.

The active ingredients of Levodopa/Carbidopa/Entacapone Teva are levodopa, carbidopa and entacapone.

• Each Levodopa/Carbidopa/Entacapone Teva film-coated tablet containing 200 mg/50 mg/200 mg contains 200 mg of levodopa, 50 mg of carbidopa and 200 mg of entacapone.
• The other components of the tablet core are microcrystalline cellulose, anhydrous lactose, low substitution hydroxypropylcellulose, povidone (K-30), anhydrous colloidal silica and magnesium stearate
• The components of the coating are titanium dioxide (E171), hypromellose, glycerol (E422), yellow iron oxide (E172), polysorbate 80, red iron oxide (E172), black iron oxide (E172) and magnesium stearate.

Appearance of Levodopa/Carbidopa/Entacapone Teva and contents of the pack
Levodopa/Carbidopa/Entacapone Teva 50 mg/12.5 mg/200 mg: light brown, biconvex, circular film-coated tablet with 50 on one side and smooth on the other. Dimensions: approximately 14 mm in diameter.
Levodopa/Carbidopa/Entacapone Teva 75 mg/18.75 mg/200 mg: pale orange, biconvex, oval film-coated tablet with 75 on one side and smooth on the other. Dimensions: approximately 16x10 mm.
Levodopa/Carbidopa/Entacapone Teva 100 mg/25 mg/200 mg: pale red, biconvex, oblong film-coated tablet with 100 on one side and smooth on the other. Dimensions: approximately 17x9 mm.
Levodopa/Carbidopa/Entacapone Teva 125 mg/31.25 mg/200 mg: yellowish brown, biconvex, circular film-coated tablet with 125 on one side and smooth on the other. Dimensions: approximately 14 mm in diameter.
Levodopa/Carbidopa/Entacapone Teva 150 mg/37.5 mg/200 mg: dark red, biconvex, oval film-coated tablet with 150 on one side and smooth on the other. Dimensions: approximately 16x10 mm.
Levodopa/Carbidopa/Entacapone Teva 175 mg/43.75 mg/200 mg: pastel brown, biconvex, elliptical film-coated tablet with 175 on one side and smooth on the other. Dimensions: approximately 17x10 mm.
Levodopa/Carbidopa/Entacapone Teva 200 mg/50 mg/200 mg: brown, biconvex, oblong film-coated tablet with 200 on one side and smooth on the other. Dimensions: approximately 17x9 mm.
Levodopa/Carbidopa/Entacapone Teva is available in packs of 10, 28, 30, 50, 60, 90, 98, 100, 130, 150, 175, 200 or 250 tablets. Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer
Teva Italia S.r.l. - Piazzale Luigi Cadorna, 4 - 20123 Milan
Manufacturer
TEVA Gyógyszergyár Zrt. (TEVA Pharmaceutical Works Private Limited Company) Debrecen, Pallagi út 13, Hungary
TEVA UK Ltd, Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG, United Kingdom
Teva Pharma B.V., Swensweg 5, Haarlem, 2031 GA, Netherlands
Merckle GmbH, Ludwig-Merckle-Straße 3, Blaubeuren, 89143, Germany

This medicinal product is authorised in the Member States of the European Economic Area under the following designations:
Austria Levodopa/Carbidopa/Entacapon ratiopharm 50 mg/12.5 mg/200 mg, 75 mg/18.75 mg/200 mg, 100 mg/25 mg/200 mg, 125 mg/31.25 mg/200 mg, 150 mg/37.5 mg/200 mg, 175 mg/43.75 mg/200 mg, 200 mg/50 mg/200 mg Filmtabletten
Belgium Levodopa/Carbidopa/Entacapone Teva 50 mg/12.5 mg/200 mg, 75 mg/18.75 mg/200 mg, 100 mg/25 mg/200 mg, 125 mg/31.25 mg/200 mg, 150 mg/37.5 mg/200 mg, 175 mg/43.75 mg/200 mg, 200 mg/50 mg/200 mg filmomhulde tabletten
Cyprus Levodopa+Carbidopa+Entacapone/Teva 50 mg/12,5 mg/200 mg, 75 mg/18,75 mg/200 mg, 100 mg/25 mg/200 mg, 125mg/31,25 mg/200 mg, 150 mg/37,5 mg/200 mg, 175 mg/43,75 mg/200 mg, 200 mg/50 mg/200 mg επικαλυμμένα με λεπτό υμένιο δισκία
Denmark Levodopa/Carbidopa/Entacapone Teva
Estonia Levodopa/Carbidopa/Entacapone Teva
Germany Levodopa /Carbidopa/Entacapon AbZ 50 mg/12,5 mg/200 mg, 75 mg/18,75 mg/200 mg, 100 mg/25 mg/200 mg, 125 mg/31,25 mg/200 mg, 150 mg/37,5 mg/200 mg, 175 mg/43,75 mg/200 mg, 200 mg/50 mg/200 mg Filmtabletten
Greece Levodopa+Carbidopa+Entacapone/Teva 50 mg/12,5 mg/200 mg, 75 mg/18,75 mg/200 mg, 100 mg/25 mg/200 mg, 125mg/31,25 mg/200 mg, 150 mg/37,5 mg/200 mg, 175 mg/43,75 mg/200 mg, 200 mg/50 mg/200 mg επικαλυμμένα με λεπτό υμένιο δισκία
France Levodopa/Carbidopa/Entacapone Teva 50/12,5/200 mg, 75/18,75/200 mg, 100/25/200 mg, 125/31,25/200 mg, 150/37,5/200 mg, 175/43,75/200 mg, 200/50/200 mg, comprimé pelliculé
Hungary Levodopa/Carbidopa/Entacapone Teva 50mg/12,5mg/200 mg, 75mg/18,75mg/200 mg, 100mg/25mg/200 mg, 125mg/31,25mg/200 mg, 150mg/37,5mg/200 mg, 175mg/43,75mg/200 mg, 200mg/50mg/200 mg filmtabletta
Ireland Levodopa/Carbidopa/Entacapone Teva 50 mg/12.5 mg/200 mg, 75 mg/18.75 mg/200 mg, 100 mg/25 mg/200 mg, 125mg/31.25 mg/200 mg, 150 mg/37.5 mg/200 mg, 175 mg/43.75 mg/200 mg, 200 mg/50 mg/200 mg Film-coated Tablets
Italy Levodopa/Carbidopa/Entacapone Teva
Latvia Levodopa/Carbidopa/Entacapone Teva 50 mg/12,5 mg/200 mg, 75 mg/18,75 mg/200 mg, 100 mg/25 mg/200 mg, 125mg/31,25 mg/200 mg, 150 mg/37,5 mg/200 mg, 200 mg/50 mg/200 mg apvalkotās tabletes
Lithuania Levodopa/Carbidopa/Entacapone Teva 50 mg/12,5 mg/200 mg, 75 mg/18,75 mg/200 mg, 100 mg/25 mg/200 mg, 125 mg/31,25 mg/200 mg, 150 mg/37,5 mg/200 mg, 175/43.75/200 mg, 200/50/200 mg plėvele dengtos tabletės
Luxembourg Levodopa/Carbidopa/Entacapone Teva 50 mg/12,5 mg/200 mg, 75 mg/18,75 mg/200 mg, 100 mg/25 mg/200 mg, 125 mg/31,25 mg/200 mg, 150 mg/37,5 mg/200 mg, 175 mg/43,75 mg/200 mg, 200 mg/50 mg/200 mg comprimés pelliculés
Netherlands Levodopa/Carbidopa/Entacapone Teva 50mg/12,5mg/200 mg, 75mg/18,75mg/200 mg, 100mg/25mg/200 mg, 125mg/31,25mg/200 mg, 150mg/37,5mg/200 mg, 175mg/43,75mg/200 mg, 200mg/50mg/200 mg, filmomhulde tabletten
Romania Levodopa/Carbidopa/Entacaponă Teva 50 mg/12,5 mg/200 mg, 75 mg/18,75 mg/200 mg, 100 mg/25 mg/200 mg, 125mg/31,25 mg/200 mg, 150 mg/37,5 mg/200 mg, 175 mg/43,75 mg/200 mg, 200 mg/50 mg/200 mg comprimate filmate
Republic
Slovakia Levodopa/Carbidopa/Entacapone Teva 50 mg/12.5 mg/200 mg, 75 mg/18.75 mg/200 mg, 100 mg/25 mg/200 mg, 125mg/31.25 mg/200 mg, 150 mg/37.5 mg/200 mg, 175 mg/43.75 mg/200 mg, 200 mg/50 mg/200 mg
Slovenia Levodopa/karbidopa/entakapon Teva 50 mg/12,5 mg/200 mg, 75 mg/18,75 mg/200 mg, 100 mg/25 mg/200 mg, 125mg/31,25 mg/200 mg, 150 mg/37,5 mg/200 mg, 200 mg/50 mg/200 mg filmsko obložene tablete
Spain Levodopa/Carbidopa/Entacapona Teva 50/12.5/200 mg, 75/18.75/200 mg, 100/25/200 mg, 125/31.25/200 mg, 150/37.5/200 mg, 200/50/200 mg comprimidos recubiertos con película EFG
Sweden Levodopa/Carbidopa/Entacapone Teva 50mg/12,5mg/200 mg, 75mg/18,75mg/200 mg, 100mg/25mg/200 mg, 125mg/31,25mg/200 mg, 150mg/37,5mg/200 mg, 175mg/43,75mg/200 mg, 200mg/50mg/200 mg filmdragerade tabletter
United Kingdom Levodopa/Carbidopa/Entacapone Teva 50 mg/12.5 mg/200 mg, 75 mg/18.75 mg/200 mg, 100 mg/25 mg/200 mg, 125mg/31.25 mg/200 mg, 150 mg/37.5 mg/200 mg, 175 mg/43.75 mg/200 mg, 200 mg/50 mg/200 mg Film-coated Tablets